NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/14/2021
Back to search
Official data from USPTO
ANTIGEN DISCOVERY INC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
09/14/2021
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
04/21/2008
Registration date
03/15/2011
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
09/14/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/18/2010
First use in commerce
11/18/2010
Drawing code
3
Owner type
03
Owner location
Irvine, CA
Examiner
BUTLER, MIDGE
Law office
L70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a fanciful rendition of the literal element within two horizontal lines, with "Antigen" appearing in green with yellow dotted "i" appearing stacked above "Discovery Inc" in black.
Holders and representatives
Holders
Immport Therapeutics, Inc.
Representatives
Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic agentspreparations and substances for medical purposes
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/14/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/14/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/14/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
05/13/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/15/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/26/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/26/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/26/2017
E815
TEAS SECTION 8 & 15 RECEIVED
03/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/05/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/04/2011
ALIE
ASSIGNED TO LIE
02/02/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/02/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/01/2011
IUAF
USE AMENDMENT FILED
01/27/2011
EISU
TEAS STATEMENT OF USE RECEIVED
01/27/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/14/2010
EX3G
SOU EXTENSION 3 GRANTED
09/13/2010
EXT3
SOU EXTENSION 3 FILED
09/09/2010
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/07/2010
EX2G
SOU EXTENSION 2 GRANTED
04/06/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/06/2010
EXT2
SOU EXTENSION 2 FILED
03/10/2010
EEXT
SOU TEAS EXTENSION RECEIVED
03/10/2010
EX1G
SOU EXTENSION 1 GRANTED
09/09/2009
EXT1
SOU EXTENSION 1 FILED
09/09/2009
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/10/2009
PUBO
PUBLISHED FOR OPPOSITION
12/16/2008
NPUB
NOTICE OF PUBLICATION
11/26/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/13/2008
ALIE
ASSIGNED TO LIE
11/13/2008
ALIE
ASSIGNED TO LIE
10/27/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2008
ALIE
ASSIGNED TO LIE
10/02/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2008
GNRT
NON-FINAL ACTION E-MAILED
08/12/2008
CNRT
NON-FINAL ACTION WRITTEN
08/12/2008
DOCK
ASSIGNED TO EXAMINER
08/04/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/25/2008
NWAP
NEW APPLICATION ENTERED
04/24/2008
Continuous trademark protection
Get notified about every new filing that threatens ANTIGEN DISCOVERY INC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.